SCHEMBL24453083

SCHEMBL24453083

NC(=O)NC(=O)N[C@@H](CO)Cc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.57
CYP3A4 P08684 1/20 0.57
ROCK2 O75116 5/20 0.53
ROCK1 Q13464 5/20 0.53
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
KMT2A Q03164 2/20 0.50
RPS6KA5 O75582 2/20 0.49
RPS6KA4 O75676 2/20 0.49
PRKACA P17612 2/20 0.49
GSK3B P49841 2/20 0.49
PRKX P51817 2/20 0.49
PRKG1 Q13976 2/20 0.49
CLK4 Q9HAZ1 2/20 0.49
GSK3A P49840 1/20 0.49
IRAK1 P51617 1/20 0.49
PKN2 Q16513 1/20 0.49
SGK2 Q9HBY8 1/20 0.49
LMNA P02545 1/20 0.48
PIN1 Q13526 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30289970 0.87 MAPK1 (0.64) MAPK1CYP3A4ROCK2ROCK1NPC1
SCHEMBL3956725 0.87 MAPK1 (0.64) MAPK1CYP3A4ROCK2ROCK1NPC1
SCHEMBL4619656 0.87 MAPK1 (0.64) MAPK1CYP3A4ROCK2ROCK1NPC1
SCHEMBL3959317 0.83 MAPK1 (0.68) MAPK1CYP3A4ROCK2ROCK1NPC1
SCHEMBL3897966 0.83 MAPK1 (0.68) MAPK1CYP3A4ROCK2ROCK1NPC1
SCHEMBL2973301 0.83 MAPK1 (0.68) MAPK1CYP3A4ROCK2ROCK1NPC1
SCHEMBL4330755 0.80 MAPK1 (0.68) MAPK1CYP3A4ROCK2ROCK1NPC1
SCHEMBL26527726 0.79 NAALAD2 (0.61) KMT2AMMEMEN1
SCHEMBL4344248 0.78 MAPK1 (0.66) MAPK1CYP3A4ROCK2ROCK1NPC1
SCHEMBL24453079 0.78 MAPK1 (0.69) MAPK1CYP3A4ROCK2ROCK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242476-A1 A PROCESS FOR THE PURIFICATION OF (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE FLAMMA SPA (IT) 2023-08-03 US disclosed
US-20230242476-A1 A PROCESS FOR THE PURIFICATION OF (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE FLAMMA SPA (IT) 2023-08-03 US disclosed
US-20220162159-A1 PROCESS FOR THE PREPARATION OF SOLRIAMFETOL AND SALT THEREOF ALIVUS LIFE SCIENCES LIMITED (IN) 2022-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220162159-A1 PROCESS FOR THE PREPARATION OF SOLRIAMFETOL AND SALT THEREOF TST, SPR, STS MAPK1 833/4885CYP3A4 3265/4885ROCK2 4066/4885
US-20230242476-A1 A PROCESS FOR THE PURIFICATION OF (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE PHYKPL, BPHL, DNPEP MAPK1 3019/4885CYP3A4 1272/4885ROCK2 1118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.